US Trustee Flags Sacklers' Release, Atty Fees In Purdue Plan
The U.S. Trustee's Office on Monday objected to Purdue Pharma's proposed Chapter 11 plan, pointing to the "extraordinarily broad release" of the Sackler family from opioid crisis-related claims and up to...To view the full article, register now.
Already a subscriber? Click here to view full article